Biology Reference
In-Depth Information
Ludwig E, Silberstein FC, van Empel J, Er¯e V, Neumann M, Brack-Werner R. 1999. Diminished
rev-mediated stimulation of human immunode®ciency virus type 1 protein synthesis is a hall-
mark of human astrocytes. J Virol 73: 8279±8289.
Mariani R, Rutter G, Harris ME, Hope TJ, Krausslich HG, Landau NR. 2000. A block to human
immunode®ciency virus type 1 assembly in murine cells. J Virol 74: 3859±3870.
Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, Lukyanov SA.
1999. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol 17: 969±
973.
McSharry JJ. 2000. Analysis of virus-infected cells by ¯ow cytometry. Methods 21: 249±257.
Millar DP. 1996. Time-resolved ¯uorescence spectroscopy. Curr Opin Struct Biol 6: 637±642.
Mueller S, Wimmer E. 1998. Expression of foreign proteins by poliovirus polyprotein fusion: anal-
ysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading
frames. J Virol 72: 20±31.
Muller B, Tessmer U, Schubert U, Krausslich HG. 2000. Human immunode®ciency virus type 1
Vpr protein is incorporated into the virion in signi®cantly smaller amounts than Gag and is
phosphorylated in infected cells. J Virol 74: 9727±9731.
Muthumani K, Montaner LJ, Ayyavoo V, Weiner DB. 2000. Vpr-GFP virion particle identi®es
HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells. DNA Cell
Biol 19: 179±188.
Nichols JE, Mock DJ, Roberts Jr NJ. 1993. Use of FITC-labeled in¯uenza virus and ¯ow cyto-
metry to assess binding and internalization of virus by monocytes-macrophages and lympho-
cytes. Arch Virol 130: 441±455.
Okui N, Sakuma R, Kobayashi N, Yoshikura H, Kitamura T, Chiba J, Kitamura Y. 2000. Pack-
ageable antiviral therapeutics against human immunode®ciency virus type 1: virion-targeted
virus inactivation by incorporation of a single-chain antibody against viral integrase into prog-
eny virions. Hum Gene Ther 11: 537±546.
Orsini MJ, Parent JL, Mondell SJ, Benovic JL, Marchese A. 1999. Tra½cking of the HIV cor-
eceptor CXCR4. Role of arresting and identi®cation of residues in the c-terminal tail that
mediate receptor internalization. J Biol Chem 274: 31076±31086.
Page KA, Liegler T, Feinberg MB. 1997. Use of a green ¯uorescent protein as a marker for human
immunode®ciency virus type 1 infection. AIDS Res Hum Retroviruses 13: 1077±1081.
Park IW, Sodroski J. 1996. Targeting a foreign protein into virion particles by fusion with the Vpx
protein of simian immunode®ciency virus. J Acquir Immune De®c Syndr Hum Retrovirol 11:
341±350.
Pelchen-Matthews A, Signoret N, Klasse PJ, Fraile-Ramos A, Marsh M. 1999. Chemokine receptor
tra½cking and viral replication. Immunol Rev 168: 33±49.
Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ. 2000. A compilation of cellular tran-
scription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28: 663±668.
Perrin-Tricaud C, Davoust J, Jones IM. 1999. Tagging the human immunode®ciency virus Gag
protein with green ¯uorescent protein. Minimal evidence for colocalisation with actin. Virology
255: 20±25.
Pluymers W, Cherepanov P, Schols D, De Clercq E, Debyser Z. 1999. Nuclear localization of
human immunode®ciency virus type 1 integrase expressed as a fusion protein with green ¯uo-
rescent protein. Virology 258: 327±332.
Pollard VW, Malim MH. 1998. The HIV-1 Rev protein. Annu Rev Microbiol 52: 491±532.
Sandefur S, Varthakavi V, Spearman P. 1998. The I domain is required for e½cient plasma mem-
brane binding of human immunode®ciency virus type 1 Pr55Gag. J Virol 72: 2723±2732.
Sandefur S, Smith RM, Varthakavi V, Spearman P. 2000. Mapping and characterization of the
N-terminal I domain of human immunode®ciency virus type 1 Pr55(Gag). J Virol 74: 7238±
7249.
